These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35259919)

  • 41. Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures.
    Walker CL
    Mol Endocrinol; 2016 Aug; 30(8):848-55. PubMed ID: 27355193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ethical implications of epigenetics in the era of personalized medicine.
    Santaló J; Berdasco M
    Clin Epigenetics; 2022 Mar; 14(1):44. PubMed ID: 35337378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minireview: Epigenetics of obesity and diabetes in humans.
    Slomko H; Heo HJ; Einstein FH
    Endocrinology; 2012 Mar; 153(3):1025-30. PubMed ID: 22253427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interview with Stephen B Baylin.
    Baylin SB
    Epigenomics; 2015; 7(6):881-3. PubMed ID: 26418030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Data science using the human epigenome for predicting multifactorial diseases and symptoms.
    Nishitani S; Smith AK; Tomoda A; Fujisawa TX
    Epigenomics; 2024 Mar; 16(5):273-276. PubMed ID: 38312014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased understanding of the impact of environmental exposures on the epigenome.
    O'Hagan HM; Tang WY
    Environ Mol Mutagen; 2014 Apr; 55(3):151-4. PubMed ID: 24339126
    [No Abstract]   [Full Text] [Related]  

  • 48. Drugging the epigenome in the age of precision medicine.
    Feehley T; O'Donnell CW; Mendlein J; Karande M; McCauley T
    Clin Epigenetics; 2023 Jan; 15(1):6. PubMed ID: 36631803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Public knowledge and opinion of epigenetics and epigenetic concepts.
    Lynch F; Lewis S; Macciocca I; Craig JM
    J Dev Orig Health Dis; 2022 Aug; 13(4):431-440. PubMed ID: 34503601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenomic technologies: an interview with Jörg Tost.
    Tost J
    Epigenomics; 2022 Mar; 14(6):359-363. PubMed ID: 35089083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between genome and epigenome--challenges and requirements for future research.
    Almouzni G; Altucci L; Amati B; Ashley N; Baulcombe D; Beaujean N; Bock C; Bongcam-Rudloff E; Bousquet J; Braun S; Bressac-de Paillerets B; Bussemakers M; Clarke L; Conesa A; Estivill X; Fazeli A; Grgurević N; Gut I; Heijmans BT; Hermouet S; Houwing-Duistermaat J; Iacobucci I; Ilaš J; Kandimalla R; Krauss-Etschmann S; Lasko P; Lehmann S; Lindroth A; Majdič G; Marcotte E; Martinelli G; Martinet N; Meyer E; Miceli C; Mills K; Moreno-Villanueva M; Morvan G; Nickel D; Niesler B; Nowacki M; Nowak J; Ossowski S; Pelizzola M; Pochet R; Potočnik U; Radwanska M; Raes J; Rattray M; Robinson MD; Roelen B; Sauer S; Schinzer D; Slagboom E; Spector T; Stunnenberg HG; Tiligada E; Torres-Padilla ME; Tsonaka R; Van Soom A; Vidaković M; Widschwendter M
    BMC Genomics; 2014 Jun; 15(1):487. PubMed ID: 24942464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary Modulation of the Epigenome.
    Ideraabdullah FY; Zeisel SH
    Physiol Rev; 2018 Apr; 98(2):667-695. PubMed ID: 29442595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The epigenome as a target for heritable environmental disruptions of cellular function.
    McCarrey JR
    Mol Cell Endocrinol; 2012 May; 354(1-2):9-15. PubMed ID: 21970811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interview. Epigenomics, imprinting and disease susceptibility.
    Jirtle RL
    Pharmacogenomics; 2008 Dec; 9(12):1791-5. PubMed ID: 19072637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From promises to practical strategies in epigenetic epidemiology.
    Mill J; Heijmans BT
    Nat Rev Genet; 2013 Aug; 14(8):585-94. PubMed ID: 23817309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour.
    Haseltine WA
    Regen Med; 2011 Jul; 6(4):431-5. PubMed ID: 21749201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Life as an early career researcher: interview with Catherine Martel.
    Martel C
    Future Sci OA; 2016 Mar; 2(1):FSO108. PubMed ID: 28031952
    [No Abstract]   [Full Text] [Related]  

  • 58. Early life precursors, epigenetics, and the development of food allergy.
    Hong X; Wang X
    Semin Immunopathol; 2012 Sep; 34(5):655-69. PubMed ID: 22777545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Linking epidemiology to epigenomics--where are we today?
    Ulrich CM; Grady WM
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1505-8. PubMed ID: 21149325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases.
    Qureshi IA; Mehler MF
    Neurotherapeutics; 2014 Oct; 11(4):708-20. PubMed ID: 25261112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.